Reuters logo
BRIEF-Amgen submits applications in the U.S. and Europe to expand current indication for xgeva
April 4, 2017 / 1:15 PM / 8 months ago

BRIEF-Amgen submits applications in the U.S. and Europe to expand current indication for xgeva

April 4 (Reuters) - Amgen Inc:

* Amgen submits applications in the us and europe to expand current indication for xgeva® (denosumab) to include patients with multiple myeloma

* Amgen Inc - submission of sbla to fda, application for a variation to marketing authorization to ema for xgeva Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below